Diality to Unveil Moda-flx Hemodialysis System, Poster Data at ASN Kidney Week 2023
01 Nov 2023
Platform designed to deliver flexibility, ease of use and mobility in dialysis care
IRVINE, Calif.--(BUSINESS WIRE)-- Diality Inc. today announced that it will introduce its Moda-flx Hemodialysis System™ at ASN Kidney Week 2023, Nov. 1-5 at the Pennsylvania Convention Center in Philadelphia. The technology will also be the subject of a poster session titled “Blood Flowrate Accuracy with Diality Hemodialysis System” [SA-P0618] to be presented from 10 a.m. to noon on Saturday, Nov. 4 in the exhibit hall.
Moda-flx is a patient-inspired hemodialysis system designed to empower healthcare professionals to choose what is best for patients, as well as their clinical practice. The Diality system, which is currently not approved for sale in any region, is designed to allow healthcare professionals to choose:
The right hemodialysis prescription in any care setting
The water/dialysate-generation option based on what works best for them
An interface that is easy to learn and use for specialists and non-nephrology clinicians
“Moda-flx is designed to deliver on Diality’s mission to improve lives impacted by kidney disease by reducing the burden of care for all kidney care stakeholders,” said Osman Khawar, M.D., chief executive officer for Diality. “We believe it will represent a new paradigm in the treatment of kidney disease, and we’re excited to introduce it to the kidney care community at Kidney Week.”
To view and learn more about the system, please visit Diality at ASN Kidney Week booth #2011.
About Diality
Headquartered in Irvine, Calif., Diality is a medical technology company developing a user-friendly, mobile, and connected hemodialysis system with a category-leading prescription range. The Diality system is designed to offer kidney care providers maximum flexibility as the market continues to evolve toward delivery of dialysis in a broader range of healthcare settings. Diality’s hemodialysis system is currently not approved for sale in any region. To learn more, please visit or find us on LinkedIn.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.